Vascular Medicine Twitter Journal Club
Continuing medical education (CME) credits and maintenance of certification (MOC) points are available for participating in the Vascular Medicine Twitter Journal Club. This opportunity is made possible through a joint partnership with University of Virginia School of Medicine (UVASOM). There are no fees to participate in the activity or claim credit; however, there may be a fee to download the article from the Vascular Medicine website if you do not have an active subscription or journal access.
Please note: CME and MOC credit are available only for journal club activities occurring after January 2019 and until 30 days after the session. ABIM credit will be reported every 60 days. Credit received after November 30th of each year will be applied to the following year. IMPORTANT: Your ABIM number must be in your UVASOM profile to be reported.
- Improve knowledge, competency, performance, and patient outcomes in vascular medicine
- Recognize clinical manifestations of common and uncommon vascular diseases
- Review diagnostic approach and medical, endovascular, and surgical therapies for vascular diseases
- Identify knowledge gaps in the field of vascular medicine and opportunities for future research
UVASOM is accredited by the ACCME to provide continuing medical education for physicians. UVASOM designates this journal-based CME activity for a maximum of one AMA PRA Category 1 Credit™. Participants should claim only the credit commensurate with the extent of their participation in the activity. UVASOM, as an accredited provider, awards 1 hour of participation (consistent with the one AMA PRA Category 1 Credit™) to participants who successfully complete this educational activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to one MOC II point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC II credit. UVASOM maintains a record of participation for 6 years.
The faculty, staff and planning committee of the University of Virginia Office of Continuing Medical Education have no financial affiliations to disclose. The CME planning committee disclosed the following: Heather Gornik is supported by CVR Global and receives intellectual property rights from Summit Doppler Systems, Inc. and intellectual property rights and stock/ownership from FlexLife Health. Aditya Sharma is supported by National Institute of Health Sciences, AstraZeneca, and Biomet Biologics. Geoff Barnes is supported by Pfizer/Bristol-Myers Squibb (BMS), Blue Cross Blue Shield of Michigan, and the National Heart, Lung, and Blood Institute and serves as a consultant for Pfizer/BMS, Janssen, and Portola. Valerie Clark has no financial affiliations to disclose. The author disclosures are listed in each article.
Participants are expected to participate in the 1-hour Vascular Medicine Journal Club discussion, which takes place on Twitter (@VMJ_SVM) using #VascMedJC. You must include #VascMedJC in your tweet to be eligible for credit. Then, complete the post-activity evaluation and MOC questions based on discussion of the article to receive credit.
- Click the link: https://cmetracker.net/UVA/Publisher?page=pubOpen#/getCertificate
- Sign in or create an account
- Complete the post-test, evaluation, and MOC questions (your ABIM number is required for MOC credit)
- Complete the evaluation and MOC questions
- Claim your certificate
NOTE: CME and MOC credit are available only for journal club activities occurring after January 2019 and until 30 days after the session. ABIM credit will be reported every 60 days. Credit received after November 30th of each year will be applied to the following year. IMPORTANT: Your ABIM number must be in your UVASOM profile to be reported.
Journal Club Date
Journal Club Materials
Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims
Net clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage
The conundrum of resuming anticoagulant therapy after intracerebral bleeding: in whom, when, and how?
Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial
Postoperative opioid prescribing patterns and use after vascular surgery
Opioids in vascular surgery: A call to action
The University of Virginia School of Medicine (UVASOM), as an ACCME accredited provider endorses and strives to comply with the Accreditation Council for Continuing Medical Education (ACCME) Standards of Commercial Support, Content Integrity Standards, Commonwealth of Virginia statutes, University of Virginia policies and procedures, and associated federal and private regulations and guidelines on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing education activities under our auspices.
The UVASOM requires that all CE activities accredited through this institution be developed independently and be scientifically rigorous, balanced and objective in the presentation/discussion of its content, theories and practices.
All faculty presenters participating in an accredited CE activity are expected to disclose relevant financial relationships with commercial entities occurring within the past 12 months (such as grants or research support, employee, consultant, stock holder, member of speaker’s bureau, etc.). The UVASOM will employ appropriate mechanisms to resolve potential conflicts of interest to maintain the standards of fair and balanced education to the participant. Questions about specific strategies can be directed to the Office of Continuing Medical Education, UVASOM, Charlottesville, Virginia.
The UVASOM requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. It is recommended that each clinician fully review all the available data on new products or procedures prior to clinical use.